from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0015c/pknA

LFCtreatmentdescriptionclass of inhibitor

-0.018

Amikacinug/mL Amikacintranslation

-1.254

Cap5-10ug/mL Capreomycintranslation

-0.934

Rox10-50 ug/mL Roxithromycintranslation

-0.570

SM2-5 ug/mL Streptomycintranslation

-1.775

Tet5-10 ug/mL Tetracyclinetranslation

0.868

Rif0.2-5ug/mL Rifampicintranscription

0.310

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.226

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.124

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.189

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.121

Clofazimine10-13 ug/mL Clofaziminerespiration

0.013

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.706

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.453

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.949

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.198

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.276

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.199

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.052

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.343

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.831

KCN5-20 ug/mL Potassium cyaniderespiration

-0.055

NaN30.2-2 mM Sodium aziderespiration

-0.367

Nigericin50 uM Nigericinrespiration

0.541

TRC10-150 ug/mL Triclosanrespiration

0.319

TRZ10-25 ug/mL Thioridazinerespiration

-0.560

Valinomycin0.5-10 uM Valinomycinrespiration

-0.496

ZnSO42 mM ZnSO4respiration

-0.355

menadione6-10 ug/mL Menadionerespiration

-0.072

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.090

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.073

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.209

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.878

NRP_1Non-replicating persistence stage 1dosRassociated

-0.431

Amp0.2mg/mL AmpicillincellWall

-0.071

Cephalexin20-100 ug/mL CephalexincellWall

0.162

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.349

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.195

EMB10-20 ug/mL EthambutolcellWall

-0.501

Eta12-40 ug/mL EthionamidecellWall

-0.545

INH0.2-0.4 ug/mL IsoniazidcellWall

0.274

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.732

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.435

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.065

BZA0.12 mg/mL BenzamidearomaticAmides

-0.398

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.174

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.662

H2O24 mM hydrogen peroxideDNAdamaging

-0.201

Levo10 ug/mL LevofloxacinDNAdamaging

-1.107

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.274

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.133

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.054

UVUV-irradiationDNAdamaging

0.241

ARP41-4 ug/mL Antitubercular compound ARP4?

0.229

Antimycin12.5-50 ug/mL Antimycin A?

-0.093

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.367

PA_110-50 ug/mL Antitubercular compound PA-1?

0.373

PA_2110-50 ug/mL Antitubercular compound PA-21?

3.229

PA8240.2-2 ug/mL PA-824?

1.405

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.978

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.092

Verapamil50 uM Verapamil?

0.032

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.181

methoxatin10-20 ug/mL Methoxatin?